Skip to content

Clinical evaluation of a mucoadhesive oral film containing chitosan on the treatment of recurrent aphthous stomatitis: A randomized, double-blind study

Clinical evaluation of a innovative wound covering material on the treatment of recurrent aphthous stomatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16008970
Enrollment
Unknown
Registered
2016-08-04
Start date
2016-08-22
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent aphthous stomatitis

Interventions

Test group:mucoadhesive oral film containing chitosan
Control group:mucoadhesive oral film with no active ingredients

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Aged between 18 and 60 years; (2) Volunteered to participate in this study and could precisely follow the study protocol; (3) Willing to sign the informed consent form and offer the medical history; (4) A history of RAS for a minimum of 6 months with an average healing time of at least 5 days; (5) Fresh ulcers available within less than 48 hours from eruption; (6) No drugs had been used to treat the fresh ulcers and participants were not in any other clinical trials.

Exclusion criteria

Exclusion criteria: (1) Herpetiform ulcers or major aphthous ulcer; (2) Ulcers associated with systemic diseases, such as Behcets disease or Crohns disease; (3) Patients suffering from severe diseases including but not limited to arrhythmia, uncontrolled hypertension, diabetes, hepatitis and renal failure; (4) Pregnant or lactating women, as well as those who were preparing for pregnancy during the study; (5) Poor health that cannot be fasted for 2 hours; (6) Poor oral hygiene requiring treatment; (7) Allergic to shrimp, crab, shellfish and sesame oil; (8) Received analgesics within 24 hours, antibiotics within 1 month and glucocorticoids and immunosuppressors within 3 months; (9) Patients suffering from chronic diseases, that required treatment with antibiotics, hormones, non-steroidal anti-inflammatory drugs, immunosuppressants, immunoenhancers, cytotoxic drugs or cell cycle agents which have effects on the oral mucosa; (10) Patients with mental diseases or limited in mental capacity.

Design outcomes

Primary

MeasureTime frame
ulcer size;ulcer pain score;

Countries

China

Contacts

Public ContactHaiwen Zhou

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

haiwen39@126.com+86 13916864387

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 21, 2026